Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	11/29/2004 10:31:39 AM
	of 625

Interesting snippet from the recent results statement seems to indicate that glaucoma might not be a dead indication for them, even if Trabio is... I am also delighted to welcome four new members to our Scientific Advisory Board (SAB): Professor John Forrester (ophthalmology), Professor Stephen Holgate (asthma), Professor Peng Khaw (glaucoma/ophthalmology) and Professor Stephen O'Rahilly (diabetes). They are all well-known specialists in their fields and will bring fresh perspectives to the evolution of the company's scientific endeavours -- ensuring that CAT has access to the experience it needs as it focuses further on its chosen areas and maintains its position of scientific leadership...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next